Medicare Enrolled
Dr. Purva Sharma, MD
Hematology & Oncology · Bronx, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sharma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sharma?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sharma
Dr. Purva Sharma is a hematology & oncology specialist in Bronx, NY, with 15 years of NPI registration. Based on federal Medicare data, Dr. Sharma performed 5,801 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sharma received a total of $630 from 17 pharmaceutical and/or device companies across 28 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sharma is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ Top 23% volume in NY
$630 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,801
Medicare services
Top 23% in NY for hematology & oncology
Not available
Unique patients (not deduplicated)
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,940 | $19 | $85 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
650 | $0 | $4 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
269 | $8 | $106 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
214 | $10 | $76 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
202 | $8 | $19 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
169 | $98 | $432 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
123 | $24 | $153 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
114 | $141 | $592 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
112 | $12 | $158 |
| Intensity-modulated radiation therapy delivery Delivery of radiation therapy using narrow beams that are spatially and temporally modulated to target specific areas. This process is performed per treatment session. |
108 | $286 | $3,245 |
| CT guidance for radiation therapy This procedure uses computed tomography imaging to guide the precise placement of radiation therapy fields. It ensures accurate positioning for targeted treatment delivery. |
102 | $61 | $472 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
97 | $110 | $668 |
| New patient office visit, complex (60-74 min) | 56 | $172 | $793 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
53 | $5 | $50 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
51 | $14 | $103 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
49 | $4 | $50 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
48 | $7 | $75 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
47 | $6 | $30 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
40 | $51 | $388 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
36 | $24 | $140 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
32 | $2 | $23 |
| Continuing radiation therapy consultation per week A weekly consultation to review and manage ongoing radiation therapy treatment. |
31 | $68 | $255 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
30 | $13 | $150 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
28 | $54 | $375 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
28 | $1 | $6 |
| Iron level test | 27 | $6 | $70 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
27 | $9 | $125 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 27 | $353 | $2,426 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
22 | $16 | $106 |
| PSA test (prostate cancer screening) | 21 | $18 | $50 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
21 | $0 | $79 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
16 | $30 | $139 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
11 | $29 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
5.9% high complexity
70.7% medium
23.4% routine
Industry Payment Transparency
Open Payments through 2023 ↗$630
Total received (2018-2023)
Avg $157/year across 4 years
Bottom 36% in NY for hematology & oncology
17
Companies
28
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2023
$72
2022
$491
2019
$12
2018
$55
Payments by company (2023)
PFIZER INC.
$20
BeiGene USA, Inc.
$19
Merck Sharp & Dohme LLC
$17
Daiichi Sankyo Inc.
$16
Top 3 companies account for 77.2% of 2023 payments
All-time payments by company (2018-2023) ›
Novartis Pharmaceuticals Corporation
$104
Janssen Biotech, Inc.
$88
Amgen Inc.
$80
PFIZER INC.
$44
Merck Sharp & Dohme LLC
$40
Celgene Corporation
$39
Foundation Medicine, Inc.
$36
Genmab U.S., Inc.
$27
E.R. Squibb & Sons, L.L.C.
$26
Taiho Oncology, Inc.
$26
Janssen Pharmaceuticals, Inc
$23
Octapharma USA, Inc.
$20
BeiGene USA, Inc.
$19
Daiichi Sankyo Inc.
$16
Global Blood Therapeutics, Inc.
$15
Pharmacyclics LLC, an AbbVie Company
$15
Seattle Genetics, Inc.
$12
Top 3 companies account for 43.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · BRUKINSA · DARZALEX · Enhertu · FOUNDATIONONE · IBRANCE · IMBRUVICA · KEYTRUDA · KISQALI · Kyprolis · LONSURF · OPDIVO · OXBRYTA · PANZYGA · Pomalyst · REBLOZYL · TIVDAK · XARELTO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
743
County median income
$49,036
Nearest hospital to ZIP centroid (approximate)
ST BARNABAS HOSPITAL
0.9 mi
0.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sharma is a mixed practice specialist, with above-average Medicare volume (top 23% in NY), with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sharma experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Sharma performed 2,940 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sharma receive payments from pharmaceutical companies?
Yes. Dr. Sharma received a total of $630 from 17 companies across 28 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sharma's costs compare to other hematology & oncology specialists in Bronx?
Dr. Sharma's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sharma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Bronx
Browse hematology & oncology specialists in Bronx ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology